Farnesyltransferase inhibitor BMS-214662 induces apoptosis in myeloma cells through PUMA up-regulation, Bax and Bak activation, and Mcl-1 elimination.
作者:
主题词
烷基和芳基转移酶类(Alkyl and Aryl Transferases);细胞凋亡(Apoptosis);凋亡调节蛋白质类(Apoptosis Regulatory Proteins);苯二氮|艹卓|类(Benzodiazepines);细胞系, 肿瘤(Cell Line, Tumor);剂量效应关系, 药物(Dose-Response Relationship, Drug);酶抑制剂(Enzyme Inhibitors);法尼基转转移酶(Farnesyltranstransferase);人类(Humans);咪唑类(Imidazoles);膜蛋白质类(Membrane Proteins);多发性骨髓瘤(Multiple Myeloma);肿瘤蛋白质类(Neoplasm Proteins);原癌基因蛋白质类(Proto-Oncogene Proteins);原癌基因蛋白质c-bcl-2(Proto-Oncogene Proteins c-bcl-2);肿瘤抑制蛋白质p53(Tumor Suppressor Protein p53);增量调节(Up-Regulation);bcl-2同源拮抗杀伤蛋白质(bcl-2 Homologous Antagonist-Killer Protein);bcl-2相关X蛋白质(bcl-2-Associated X Protein)
DOI
10.1124/mol.104.007021
PMID
15738311
发布时间
2025-02-13
- 浏览49

Molecular pharmacology
1991-8页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文